BPG is committed to discovery and dissemination of knowledge
Case Report
©The Author(s) 2023.
World J Clin Cases. Oct 6, 2023; 11(28): 6823-6830
Published online Oct 6, 2023. doi: 10.12998/wjcc.v11.i28.6823
Table 1 Cases of pancreatic carcinoma associated with polymyositis and myopathy
Ref.
Sex/age
Statin use
Clinical presentation
Cancer type
Diagnosis
Treatment
Gemcitabine use
Additional findings
Follow-up and outcome
Kida et al[19], 2007M, 53NRArthralgiaAKCTSteroidsNoLate-stageDied 4 yr
Myalgias muscolar weaknessBiopsyFluorouracil radiotherapyCarcinomaAfter diagnosis
Syrios et al[15], 2011M, 52NRWeight lossAKCTSteroidsYes-Remission
Recurrent pancreatitisEMG biopsyGemcitabine erlotinibSix months (then relapse)
Siddiqui et al[20], 2011F, 86NRMuscolar weaknessAKCTSteroidsNo-Remission
BiopsySurgerySix months
Amroun et al[21], 2012M, 47NRAbdominal painAKCTSurgeryYesMyopathyRemission
Jaundice weight loss astheniaMRI BiopsyGemcitabineDeveloped during 4th cycle of chemotherapyNine months, then death due to pneumonia
Padniewski et al[22], 2020M, 66YesGeneralized fatigueAKCTSteroidsYes, later inMyopathyGemcitabine
Muscolar weakness loose stools weight lossMRIFOLFOX followed by gemcitabineCourseDeveloped prior to gemcitabineTrial died 1 mo later
Decraene et al[23], 2021M, 69NRJaundiceNETMRISteroidsNo-Remission
Diarrhea weight lossEMG biopsySurgery carboplatinum-etoposideSix months (no recurrence)
Ozcan et al[24], 2022M, 86YesMyalgiasAKMRISteroidsYes, later inMetastaticThird line
Muscolar weaknessMRCP ERCP biopsySurgery FOLFOX followed by FOLFIRICourseCarcinomaPalliative treatment (gemcitabine and abraxane)
Present case, 2022F, 78YesJaundiceUnknownCTSteroidsNoAKI treated withDied during
Weight loss myalgias muscolar weaknessEMGReplacement therapyHospitalization


Write to the Help Desk